(Reuters) - Shares of dialysis service providers fell sharply on Wednesday after Novo Nordisk's Ozempic showed early signs of success in delaying the progression of kidney disease in diabetes patients ...
Oct 11 (Reuters) - Shares of dialysis services providers such as DaVita DVA.N and German rival Fresenius Medical Care FMEG.DE declined on Wednesday, after Novo Nordisk NOVOb.CO's Ozempic showed early ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results